Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

JNK Inhibitors

Santa Cruz Biotechnology now offers a broad range of JNK Inhibitors for use in various applications. JNK inhibitors are a crucial category of small molecules that play a vital role in the modulation of c-Jun N-terminal kinases (JNKs), which are part of the mitogen-activated protein kinase (MAPK) signaling pathways. These inhibitors are indispensable in scientific research, especially in studying cellular processes such as apoptosis, differentiation, and stress response. The ability to selectively inhibit JNK activity has allowed researchers to dissect complex signaling networks and understand the molecular underpinnings of various physiological and pathological conditions. JNK inhibitors have been widely used to explore the roles of JNK isoforms in immune responses, neural functions, and metabolic regulation. Moreover, they serve as valuable tools in explaining the cross-talk between different signaling pathways and in the development of novel experimental models. By providing precise control over JNK activity, these inhibitors facilitate the identification of key regulatory mechanisms and the discovery of potential biomarkers. Their application extends to various in vitro and in vivo models, making them versatile tools in basic and applied research. View detailed information on our available JNK Inhibitors by clicking on the product name.

SEE ALSO...

Items 11 to 13 of 13 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BI 78D3

883065-90-5sc-203840
sc-203840A
10 mg
50 mg
$204.00
$810.00
2
(1)

BI 78D3 acts as a JNK inhibitor through its ability to modulate the enzyme's phosphorylation state. Its structural features facilitate unique hydrogen bonding and hydrophobic interactions, which stabilize the enzyme-inhibitor complex. This compound exhibits a non-competitive inhibition mechanism, influencing the allosteric sites and altering the enzyme's activity without directly competing with the substrate. The resulting changes in reaction kinetics can significantly affect downstream signaling cascades.

AEG 3482

63735-71-7sc-202911
5 mg
$114.00
(0)

AEG 3482 functions as a JNK inhibitor by selectively disrupting the enzyme's active site interactions. Its unique molecular architecture allows for specific electrostatic interactions that enhance binding affinity. This compound exhibits a mixed inhibition profile, impacting both the active and allosteric sites, which leads to altered substrate turnover rates. The modulation of JNK activity by AEG 3482 can influence critical cellular pathways, showcasing its intricate role in signal transduction.

SU 3327

40045-50-9sc-296430
sc-296430A
10 mg
50 mg
$169.00
$715.00
1
(0)

SU 3327 acts as a JNK inhibitor through its ability to form stable complexes with the enzyme, primarily via hydrophobic interactions and hydrogen bonding. Its structural features enable it to preferentially bind to the enzyme's regulatory domain, thereby modulating its conformational dynamics. This compound exhibits competitive inhibition, effectively altering the kinetics of substrate binding and influencing downstream signaling cascades, highlighting its role in cellular response mechanisms.